Intelomed is developing a non-contact patient-monitoring device to improve telehealth treatment outcomes. Using only the camera of a smartphone, mCVInsight (Mobile Cardiovascular Insight) will measure the micro-changes of color of a patient’s face in order to provide clinicians with valuable diagnostics and patient data in real-time. Intelomed is currently in-market with previous patient-monitoring technology and is actively working to secure FDA-clearance for mCVInsight. Intelomed's mCVInsight is currently in the prototype stages of development.
With the StartEngine platform, users have the ability to invest in startups for as little as $100.